A Phase 1 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of GS-1811, an Afucosylated Anti-CCR8 Monoclonal Antibody, as Monotherapy and in Combination With an Anti–PD-1 Monoclonal Antibody in Adults With Advanced Solid Tumors

  • Body, Amy (Primary Chief Investigator (PCI))
  • Day, Daphne (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Monash Health Reference: RES-22-0000-696A
ERM Reference Number: 91290
Review Reference: SSA/91290/MonH-2023-371556(v1)
StatusActive
Effective start/end date22/05/23 → 21/05/28